Elsevier

Clinica Chimica Acta

Volume 498, November 2019, Pages 17-20
Clinica Chimica Acta

Brief reports
Melatonin is not stored in platelets

https://doi.org/10.1016/j.cca.2019.07.028Get rights and content

Highlights

  • No evidence found for storage of melatonin in platelets

  • Poor agreement between ELISA and LC-MS/MS assay for plasma melatonin concentrations

Abstract

Background

Melatonin is one of numerous biologically active compounds reported to be stored in platelets. As melatonin is increasingly linked to several diseases, we wanted to confirm the storage of melatonin in platelets using sensitive liquid chromatography in combination with isotope dilution tandem mass spectrometry (LC-MS/MS). The difference between melatonin levels analyzed in platelet-rich plasma (PRP) and platelet-poor plasma (PPP) served as proxy for platelet levels of melatonin.

Methods

Melatonin concentrations were analyzed in PRP and PPP from nineteen healthy volunteers by ELISA and LC-MS/MS. A Wilcoxon signed-rank test was performed to assess if the melatonin levels measured in PRP and PPP were different. Results for melatonin concentrations obtained by LC-MS/MS or ELISA were compared using Passing-Bablok regression.

Results

Comparison of the ELISA with the LC-MS/MS method showed poor agreement for melatonin concentrations in PRP and PPP. No indication was found for storage of melatonin in platelets by either LC-MS/MS or ELISA (P = .89 and P = .53 for the LC-MS/MS and ELISA analysis, respectively).

Conclusion

In this study we could find no evidence for melatonin storage in platelets.

Introduction

Over 300 bioactive components have been detected in platelet releasates [1,2]. Once secreted these bioactive components act in an autocrine or paracrine way to modulate cell signaling.

One of these bioactive components was considered to be melatonin [3]. This is of relevance given the increasing interest in the potential roles of melatonin in the human body. It is already known that melatonin is a regulator of the circadian rhythm. Deregulation of the circadian rhythm and of circulating melatonin levels are associated with increased incidence of cancer, neurological, cardiovascular and metabolic diseases, and epigenetic abnormalities [4,5].

The finding of platelet melatonin was based on an ELISA assay [3]. We developed a refined method for melatonin detection to facilitate detailed melatonin research [6]. Therefore, we also wanted to confirm the storage of melatonin in platelets using a sensitive liquid chromatography in combination with isotope dilution tandem mass spectrometry (LC-MS/MS). Platelet-rich plasma (PRP) and platelet-poor plasma (PPP) served as proxy for platelet levels of melatonin, because isolation of platelets is prone to errors [7].

Section snippets

Material and methods

Twenty healthy volunteers over 18 years of age were included. All gave written informed consent. The study was waived by the Medical Ethical Review Committee of the University Medical Center Groningen. Blood (two 10 mL EDTA tubes per volunteer) was drawn at 8:00 AM using a butterfly needle. Blood was immediately processed to minimise platelet activation [7]. To obtain PRP, one EDTA tube per volunteer was centrifuged at 120g for 30 min at room temperature. Of this, 500 μL served to determine the

Results

Comparison of the LC-MS/MS and the ELISA method showed poor agreement for melatonin concentrations in PRP (slope = 2.35 [0.65 to18]; 95% CI, intercept = −100 [−1015 to −7.3]; 95% CI) and in PPP (slope = 1.68 [1.04–2.71]; 95% CI, intercept = −61 [−123 to −27]; 95% CI) (Fig. 1).

With both techniques, we found no evidence for storage of melatonin in platelets, as no difference between PRP and PPP was detected using the Wilcoxon signed rank test, P = .89 and P = .53 for the LC-MS/MS and ELISA

Discussion and conclusion

These results show that indeed plasma contains melatonin, but melatonin is not stored in platelets.

Our results are in contrast with a study where the same ELISA was used to demonstrate presence of melatonin in platelets of only three healthy individuals [3]. This difference can be explained by the following differences, first we studied a larger group of twenty subjects. Secondly, we used the difference between PRP and PPP as proxy for platelets. Isolation of platelets is prone to errors, as it

Author contributions

Study concept and design IK, SO, EdV, acquisition, analysis, and interpretation of data MvF, MP; drafting and critical revision of the manuscript MvF, MP, AW, EdV, SO, IK.

References (16)

There are more references available in the full text version of this article.

Cited by (0)

1

These authors contributed equally.

View full text